Mekinist (Trametinib) Tablets


Medical Evidence mekinist

Generic name : Trametinib.

Trade name : Mekinist.

Manufacturer information :

Mekinist is manufactured by GlaxoSmithKline.

Mekinist FDA Approval :

Mekinist first approved May 29th, 2013.

Mekinist Dosage form :

Tablets: 0.5 mg, 1 mg, and 2 mg.

Mekinist Indications and Usage :


MEK inhibitor indicated as a single agent or in combination with dabrafenib for unresectable or metastatic melanoma with BRAF V600E or V600K mutations.

Mekinist (Trametinib) availability in India

  • You could import this medicine against import permit on Patient Name.
  • Please contact ACT Lifesciences Private Limited for further information.